-
4,4′-(1,3-Phenylenedioxy) dianiline 2479-46-1
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa kemịkalụ |Polyimide monomers |
4,4′-(1,3-Phenylenedioxy) dianiline|CAS: 2479-46-1 |C18H16N2O2
-
4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy) dianiline 13080-86-9
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ụlọ ọrụ ihe onwunwe Chemistry |Polyimide monomers |4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy) dianiline |CAS: 13080-86-9 |C27H26N2O2
-
(S) -3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester 109010-60-8
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ọrịa obi |Ọbara Ọbara |S-ATBA |CAS: 109010-60-8 |C16H22N2O3
-
(R) -2-amino-N-benzyl-3-methoxypropanamide (2R,3R) -dihydroxysuccinate 1423058-53-0
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ọrịa Neurologic |ọgwụ mgbochi epileptic |(R) -2-amino-N-benzyl-3-methoxypropanamide (2R,3R) -dihydroxysuccinate |CAS: 1423058-53-0 |C15H22N2O8
-
Lacosamide 175481-36-4
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ọrịa Neurologic |ọgwụ mgbochi epileptic |Lacosamide |CAS: 175481-36-4 |C13H18N2O3
-
4- (2-Dimethylamino) ethoxybenzylamine 20059-73-8
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |API mmepụta ihe |Ọgwụ digestive usoro |Itoppride hydrochloride na Intermediates |4- (2-Dimethylamino) ethoxybenzylamine |CAS: 20059-73-8 |C11H18N2O
-
Itopride 122898-67-3
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |API mmepụta ihe |Ọgwụ digestive usoro |Itoppride hydrochloride na Intermediates |Itopride |CAS: 122898-67-3 |C20H26N2O4
-
2- (2-Ethoxyphenoxy) ethyl bromide 3259-03-8
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |API mmepụta ihe |Ọgwụgwọ Prostatic Hyperplasia |Tamsulosin Hydrochloride Intermediates |CAS: 3259-03-8 |C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |API mmepụta ihe |Ọgwụgwọ Prostatic Hyperplasia |Tamsulosin Hydrochloride Intermediates |CAS: 116091-63-5 |C10H13NO4S
-
4- (4-Phenylbutoxy) benzoic acid 30131-16-9
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa |Ọrịa iku ume |Pranlukast Intermediates |4- (4-Phenylbutoxy) benzoic acid |CAS: 30131-16-9 |C17H18O3
-
![3′-[4-(4-Phenylbutoxy) benzoylamino]-2′-hydroxyacetophenone 136450-06-1](https://www.yisunbio.com/uploads/50.jpg)
3′-[4-(4-Phenylbutoxy) benzoylamino]-2′-hydroxyacetophenone 136450-06-1
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa |Ọrịa iku ume |Pranlukast Intermediates |3′-[4-(4-Phenylbutoxy) benzoylamino] -2′-hydroxyacetophenone |CAS: 136450-06-1 |C25H25NO4
-
3′-Amino-2′-hydroxyacetofenone 70977-72-9
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa |Ọrịa iku ume |Pranlukast Intermediates |3′-Amino-2′-hydroxyacetophenone |CAS: 70977-72-9 |C8H9NO2